What is holding back the development of antiviral metallodrugs? A literature overview and implications for SARS-CoV-2 therapeutics and future viral outbreaks. de Paiva, R., E., F., Marçal Neto, A., Santos, I., A., Jardim, A., C., G., Corbi, P., P., & Bergamini, F., R., G. Dalton Transactions, 49(45):16004-16033, 2020.
What is holding back the development of antiviral metallodrugs? A literature overview and implications for SARS-CoV-2 therapeutics and future viral outbreaks [link]Website  doi  abstract   bibtex   
Despite a significative classical literature, metallodrugs have struggled to reach clinical practice. In light of the COVID-19 outbreak, this review aims at further encouraging and promoting the development of metallodrugs as viable antiviral agents.
@article{
 title = {What is holding back the development of antiviral metallodrugs? A literature overview and implications for SARS-CoV-2 therapeutics and future viral outbreaks},
 type = {article},
 year = {2020},
 pages = {16004-16033},
 volume = {49},
 websites = {http://xlink.rsc.org/?DOI=D0DT02478C},
 id = {67819325-3faf-379b-a4f6-258a775df720},
 created = {2021-03-12T20:44:44.173Z},
 file_attached = {false},
 profile_id = {6d4e9e22-09e3-3340-83ee-25b0de1090e1},
 last_modified = {2022-03-17T15:51:56.560Z},
 read = {true},
 starred = {false},
 authored = {true},
 confirmed = {true},
 hidden = {false},
 private_publication = {false},
 abstract = {Despite a significative classical literature, metallodrugs have struggled to reach clinical practice. In light of the COVID-19 outbreak, this review aims at further encouraging and promoting the development of metallodrugs as viable antiviral agents.},
 bibtype = {article},
 author = {de Paiva, Raphael E. F. and Marçal Neto, Antônio and Santos, Igor A. and Jardim, Ana C. G. and Corbi, Pedro P. and Bergamini, Fernando R. G.},
 doi = {10.1039/D0DT02478C},
 journal = {Dalton Transactions},
 number = {45}
}

Downloads: 0